256 related articles for article (PubMed ID: 19018808)
1. Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice.
Zhou XX; Gao PJ; Sun BG
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):373-9. PubMed ID: 19018808
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway.
Yan W; Li D; Zhou X
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):344-352. PubMed ID: 27998006
[TBL] [Abstract][Full Text] [Related]
3. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice.
Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T
Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225
[TBL] [Abstract][Full Text] [Related]
6. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
[TBL] [Abstract][Full Text] [Related]
7. 17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes.
Lengi AJ; Phillips RA; Karpuzoglu E; Ahmed SA
J Mol Endocrinol; 2006 Dec; 37(3):421-32. PubMed ID: 17170083
[TBL] [Abstract][Full Text] [Related]
8. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
9. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
12. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Coptis root extract on gene expressions of perilipin and PPAR-gamma in aortic vulnerable atherosclerotic plaque of ApoE-gene knockout mice].
Zhou MX; Xu H; Chen KJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jun; 28(6):532-6. PubMed ID: 18655564
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice.
Whitman SC; Ravisankar P; Daugherty A
J Interferon Cytokine Res; 2002 Jun; 22(6):661-70. PubMed ID: 12162876
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
Park KY; Oh E; Kwak MK; Jun HS; Heo TH
PLoS One; 2016; 11(3):e0150791. PubMed ID: 26950217
[TBL] [Abstract][Full Text] [Related]
16. Sp2 regulates interferon-gamma-mediated socs1 gene expression.
Letourneur M; Valentino L; Travagli-Gross J; Bertoglio J; Pierre J
Mol Immunol; 2009 Jul; 46(11-12):2151-60. PubMed ID: 19482358
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of methamphetamine promotes atherosclerosis formation in ApoE-/- knockout mice fed normal diet.
Gao B; Li L; Zhu P; Zhang M; Hou L; Sun Y; Liu X; Peng X; Gu Y
Atherosclerosis; 2015 Nov; 243(1):268-77. PubMed ID: 26409626
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
Zhang X; Xiao S; Li Q
J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
[TBL] [Abstract][Full Text] [Related]
19. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
